chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt says she was very sick the day after taking the vax.  She had fever, body aches, chest pressure, diarhea, fatigue, cough, and SOB.  She went to her PCP and was prescribed medicine.  She did not get any better so went to Hospital ER.  She was admitted for testing.  She had blood work, EKG, stress test, X-rays.  Her potassium is low.  BP high. She was discharged to FU w/ PCP and Cardiologist.  She is still not well and has to get a MRI of her heart.
Case number PHEH2015US017902, is an initial spontaneous report from a pharmacist received on 09 Sep 2015. This report refers to a 33-year-old female patient. The patient received prefilled FLUVIRIN (batch number: 157102) intramuscularly on 09 Sep 2015. After vaccination, the patient stated that she was allergic to latex. No adverse event was reported.
Information has been received from a 42 year old female consumer who in February, 2000 and 6/16/2000 was vaccinated with the 1st and 2nd dose (Lot #1712J) of MMR II. Shortly after receiving the 2nd vaccination, the pt experienced an asthma attack and was given "inhalers" (pt has no history of asthma). On 6/19/2000, the pt experienced a heart attack and partial intermittent paralysis and was hospitalized. On 6/29/2000, the pt was taken to the hospital ER from physician therapy after a therapist was concerned that she seemed to have suffered a stroke. The pt states that she is no longer able to drive a car since DMV was notified immediately. Additional information has been requested.
Hospitalization: 9/10/2022 - 9/14/2022 Presentation to the ED: ABDOMINAL PAIN. COVID-19 + date: 9/10/22 Treatment: PAXLOVID. Discharge to: HOME.
Overdose; 18 years of received Engerix-B adult; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 18-year-old male patient who received HBV (Engerix B adult) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   In 2022, the patient received the 1st dose of Engerix B adult and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the overdose and inappropriate age at vaccine administration were unknown.  This report was made by GSK without prejudice and did not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 09-Aug-2022. Reporter's comment: The pharmacy intern stated that a month ago an 18 year old patient received an adult dose of Engerix-B. Not able to confirm whether it was the PFS or vial, so the reporter chosen PFS. Health care professional did not have the lot or exp date of the vaccine as it was administered by another facility and also declined follow up. The reporter did not consent to follow-up. Additional Supportive Information: An 18 year old patient received an adult dose of Engerix-B, which led to overdose and inappropriate age at vaccine administration.
Injection site red, swollen, itchy and painful. Two and a half weeks later there is still a circle around injection site.
This spontaneous report as received from a nurse refers to a 32 year old patient of unknown gender. On 11-DEC-2014 the patient was vaccinated with a pediatric dose of VAQTA (dose, units, route of administration, anatomical location, lot number were not reported). No adverse effects reported. Additional information has been requested.
At 4:15Pm after receiving 2 out of 3 vaccines (see below) this client, who was sitting next to the counter, fainted and hit her head at the bridge of her nose resulting in a thin red line at pt- of contact no secretion, no cut, no bruise. Cold compresses, lying on bed, given 3rd injection lying down, juice box
Immediate testicle pain.  Epididymitis that became chronic Epididymitis, progressed to bilateral Epididymitis and eventually Prostate infection.
Beginning night of 1/13 around 9pm, felt cold chills, nausea, headache, body & muscle aches, loss of appetite and fever. Tight chest and hard to breathe. Feels like asthma attack was triggered. Has been persistent symptoms since 1/13. Have been alternating Tylenol and Motrin. Using albuterol pump and vicks vaporizer, as needed.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 01-Jul-2022 past the BUD date 23-Jun-2022/ administration error) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059A22A) for COVID-19 vaccination. It was unknown if the patient was ever diagnosed with or tested COVID-19 positive. It was also unknown if there was any acute illness at the time of vaccination or any chronic or long-standing health conditions of the patient. On 01-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 01-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 01-Jul-2022 past the BUD date 23-Jun-2022/ administration error). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 01-Jul-2022 past the BUD date 23-Jun-2022/ administration error) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 01-Jul-2022 past the BUD date 23-Jun-2022/ administration error). Concomitant medications details were not reported. It was reported vaccine was administered 8 day past the BUD of 23 Jun 2022. Reporter further reported that as per Moderna, the product was still active and patient need not to be re-vaccinated. The event did not cause patient to seek the medical care. There was no other potential caused. It was unknown if patient same event in past. The treatment details were not reported. This case was linked to US-MODERNATX, INC.-MOD-2022-599989 (E2B Linked Report). Sender's Comments: US-MODERNATX, INC.-MOD-2022-599989: Master case.
Rapid heart rate  Happened 1 st time for 2 hours  two weeks after 1 st vaccine and 2nd time a week later for 3 hours
Complete body ague - immediately followed by dizziness, nausea, slight cough, heat so strong I thought my head was going to blow off, searing chest pains from cough, extreme shaking from chills followed by searing heat throughout my body, complete physical exhaustion, lethargy, bottom lip swelled to twice its size, difficulty breathing, rapid heart beat. I felt there was a clog in my chest that would not allow me to breath freely.  Chest pains were like lightening bolts that grabbed my lungs until I cried in pain.  Above symptoms continued without abate for 24 hours. I could not even remove my clothes.  I sipped water twice during these 24 hours. About 8PM on Friday night, symptoms became more tolerable.  My fever continued, however, through Saturday afternoon.  By Sunday morning, I felt normal. I am a health "nut".  I workout at my gym twice a week on muscle machines.  I swim 1/2 mile twice a week and teach yoga and take a class a minimum of once a week. I will NEVER again submit to a flu vaccine.
Case number PHEH2014US022087 is an initial spontaneous report received from a medical assistant on 31 OCT 2014. This case refers to a 10 years old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with FLUCELVAX 2014/2015 (batch number 161208) intramuscularly on 31 OCT 2014. No adverse event was reported following this administration error (inappropriate age at vaccine administration).
Patient tested positive for COVID-19; Patient received 1st dose over 3 months ago; Patient received 1st dose over 3 months ago; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Patient tested positive for COVID-19), PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose over 3 months ago) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 1st dose over 3 months ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient tested positive for COVID-19), PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose over 3 months ago) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 1st dose over 3 months ago). At the time of the report, COVID-19 (Patient tested positive for COVID-19) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose over 3 months ago) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 1st dose over 3 months ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Dizziness, nausea, sweating, headache, felt like she was going to consciousness.
Child under the age of 18 received the Moderna COVID-19 vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Child under the age of 18 received the Moderna COVID-19 vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Child under the age of 18 received the Moderna COVID-19 vaccination). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Child under the age of 18 received the Moderna COVID-19 vaccination) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was no provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up received on 21-Jun-2021 contains no new information.
Fever, pain, erythema 6 x 8 cm (R) arm.
A couple days later I developed a rash. I went home and changed my clothes thinking that it might have been an allergic reaction to something on my clothes. It stayed around for about 3 days then resolved itself. I got the vaccine on 4/08 and on 04/15 I went to the doctor because I had a rash. It was very miserable and all over my body. It showed up on the 14th. They told me to keep on Benadryl and it went away. I have now come down with Covid-19. My symptoms started 10/05. It was like a very very bad cold. I had a headache, but I did not have a fever. On Sunday the 10th, I got my positive results. It's like a cold. My nose has been burning. On the 12th, I got a rash that was very heated and red. It comes and goes. I started taking Benadryl immediately and it completely made me sleep. I would wake up with severe itching. I called my doctor on 10/12 at 1PM. I told her that my rash woke me up around 2AM. She prescribed me prednisone on the 13th. I started taking it that evening. I have some swelling in my hands and lips. My fingers have been swollen the whole time. The inflammation finally went away. I still have a rash all over my body. It comes and goes, but the itching is non stop. I still take the Benadryl and it helps for a few hours. I take about 2 Benadryl at a time. I keep waking up with severe itching. I am able to work from home. My lower legs are itching, my sides are itching, and my arms are itching. It looks like hives. I sent my doctor another message this morning asking if there was anything else they could do for me since it has not gone away. I am still in quarantine for now.
Unusual fatigue lasting all day. I woke up fatigued after a full 10 hours sleep. Low grade fever. Chills. Was better the next morning.
Right thigh hot, swollen, red, blistered size of a softball Left thigh hot, red, swollen, size of grape . Treated with ibuprofen q/6
Post vax, on 11/28/00, the pt quickly developed a 6cm X 2cm area of redness, without induration. The are was warm to the touch but subsided quickly.
Pt received 4 mo imms & Rotateq yesterday. Presented today with fever (100.5 (R) blood streaked vomitus x1, diarrhea x1, decreased appetite, scattered pink papules on abdomen. Treatment: Acetaminophen 0.8 ml po Q4hrs prn fever. Above symptoms/signs likely due to Rotateq. No Rotateq @ 6 mos
Left arm pain on Day 1; worsening pain on Day 2 and Day 3, progressive decrease in range of motion of L shoulder in succeeding days. Progressing decrease in range of motion of L shoulder from Day 4 to Day 30; pain started radiating from L upper arm to L lower arm from D31 to D60 - went to seek medical care and diagnosed with L adhesive capsulitis by an upper extremity specialist, and referred for Physical Therapy. Still on PT and still w pain as of this report on 1/5/2021.
22OCT96 devel severe itching & gen rash & wheals;cont for 3 days by itching dec & rash less pronounced today;
Two days post vax the pt developed approximately 30 lesions of chickenpox. Therapy with Zovirax 800 mg 4 times a day for 5 days was initiated. The reporter noted that blood count test conducted revealed she was 8 weeks pregnant but her uterus size indicates 4 months pregnant. It was indicated that the pt sought unspecified medical attention for the symptom. Additional information has been requested.
9/24/14 patient's mother called in to report an adverse reaction to SQ MMR.  The mother stated the child started to develop a rash 5 hours after the vaccination in the left arm.  The rash has continued to worsen and is now on the left side of body -- arm, torso, axillary, and left leg.  The client has had fevers on and off from 99 to 100 degree F.  In addition the mom reports the child is fuzzy and has not been eating well.
Fever began morning after.  Fever when woke up am after 100,  as day progressed fever up to 104.   Patient was brought by curbside rx where pharmacist assessed patient, took temp- 104.6.  Patient stated fever/chills after 2 doses of APAP. Recommended patient go to Emergency room for assessment and follow up and treatment to reduce temp, aches and chills.
NASAL CONGESTION, SORE THROAT, DRY COUGH, FATIGUE, FEVER, CHILLS ORDER FOR MAB THERAPY
Covid + infection; Covid + infection; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 26-year-old female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Nov2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 26 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 10Jan2021 as dose 1, single (Batch/Lot number: unknown) and on 04Feb2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 08Jan2023, outcome "recovering" and all described as "Covid + infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Jan2023) Positive, notes: Nasal swab. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
side effect from the Modena booster; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect from the Modena booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced VACCINATION COMPLICATION (side effect from the Modena booster). At the time of the report, VACCINATION COMPLICATION (side effect from the Modena booster) outcome was unknown.            No concomitant medications were reported  No treatment information was provided
3" ring of rash around site with a knot under the skin and tender to the touch. Started 24 hours, post vax. Recovered, 4 days after. Told to take Benadryl and use ice on the site.
pt recvd vax 430PM & 9PM fussy, irritable, 12MN fever 103 R, congested breathing, breathing rapid, & loug given APAP orally & tepid bath; 1AM breathing cont labored; no retracting; temp nl-breathing nl;
Sweeping in arm- about 1-1/2 inch diameter  has lasted 9 days now
Reddened raised area noted the size of a silver dollar. Instructions given to FOP to give Beady x  days and to apply cool compresses to site. Dime size raised area noted on R thigh PCM assessed and states Area was fine.
Patient presented to the ED and was subsequently hospitalized for a small bowel obstruction within 6 weeks of receiving COVID vaccination.
fever chills excessive sleep (i.e, 19 hours for next 24 hours) disorientation
some difficulty breathing eyes puffy, watery, itchy - much more than normal allergies lasted 48 hours
Swelling to L upper arm noted 24 hrs post shots, extended from elbow to shoulder on exam by MD 5/26/01, resolved slowly over 1 week.
Pre-heart attack; Invalid dose : deviation of time (delay between both doses more than 42 days); This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Pre-heart attack) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced MYOCARDIAL INFARCTION (Pre-heart attack) (seriousness criterion hospitalization). On 01-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Invalid dose : deviation of time (delay between both doses more than 42 days)). On 01-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Invalid dose : deviation of time (delay between both doses more than 42 days)) had resolved. At the time of the report, MYOCARDIAL INFARCTION (Pre-heart attack) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Tested positive for COVID-19; Lack of drug effect; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Tested positive for COVID-19) and DRUG INEFFECTIVE (Lack of drug effect) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03BC21A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Egg allergy. Concomitant products included SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA) for an unknown indication.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 10-Jun-2021 at 2:03 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 01-Feb-2022, the patient experienced COVID-19 (Tested positive for COVID-19) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (Tested positive for COVID-19) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2022, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient did not had any adverse events including signs symptoms,clinical course and or treatment with dates/timelines. Patient did not experience any symptoms during temperature excursion. No treatment medications were reported. COMPANY COMMENT: This is a Spontaneous case concerning a 29 -years-old male patient with clinical history of Asthma and Egg allergy, concomitant products included SALBUTAMOL SULFATE who experienced the unexpected events of COVID-19 (AESI) and DRUG INEFFECTIVE 236 days after 2nd  dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Terms and onset were captured as provided.    This case was linked to MOD-2022-504757 (Patient Link).; Sender's Comments: COMPANY COMMENT: This is a Spontaneous case concerning a 29 -years-old male patient with clinical history of Asthma and Egg allergy, concomitant products included SALBUTAMOL SULFATE who experienced the unexpected events of COVID-19 (AESI) and DRUG INEFFECTIVE 236 days after 2nd  dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Terms and onset were captured as provided.
Fever (102.0 F) Chills, body aches, pounding headache, insomnia from 12:01AM - 5:30AM 3/20/21  From 5:30AM- 4:30 PM - exhaustion, headache   Starting at 4:30 PM on 3/20/21 (after 2 hour nap) felt great!!   On and off lingering tiredness for a couple more days
Pt. woke up on 1/13/21 throwing up, this continued throughout the day about 5 episodes total.  Pt. had no appetite that day and drank or ate very little. During the night on 1/13/21, he woke up and when his caregiver tried to help him to the bathroom, he had weakness on the right side of his body. Caregiver called on 1/14/21 letting us know the pt. has increased weakness. Caregiver encouraged to take pt. to Er. Pt. refused.   Pt. seen in clinic on 1/15/21 and examination found pt. to have right hemiparesis including foot drip, right arm weakness, loss of motor control on the right upper and lower extremities. Facial droop on the right with disarticulation of speech and control of the tongue.
Measles looking like rash on torso; Rash on arm; Feeling tired; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH MORBILLIFORM (Measles looking like rash on torso), RASH (Rash on arm) and FATIGUE (Feeling tired) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced RASH MORBILLIFORM (Measles looking like rash on torso), RASH (Rash on arm) and FATIGUE (Feeling tired). At the time of the report, RASH MORBILLIFORM (Measles looking like rash on torso), RASH (Rash on arm) and FATIGUE (Feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
3rd HPV vaccine given too early   HPV #1 11-21-06, HPV #2 1-25-07,  HPV # 3 given 3-22-07